Abnormal Hepatobiliary System Physiology C6016356
Disruption in how the liver and bile system work together. It can result from various liver conditions affecting digestion and toxin processing. Management focuses on treating the underlying cause.
Key facts at a glance
- ICD-10
- K76.9
- ICD-11
- DA00.0
- Body system
- hepatobiliary
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Confusion and disorientation
Altered mental status, difficulty concentrating, and confusion due to hepatic encephalopathy from toxin buildup.
This is a medical emergency. Seek immediate emergency care if confusion or altered consciousness develops.
Yellowing of skin and eyes
(dermatologic)Yellow discoloration of the skin, sclera, and mucous membranes caused by elevated bilirubin levels in the blood.
Frequency: 70-80% of patients
Right upper quadrant pain
(gastrointestinal)Dull or aching pain in the upper right abdomen below the ribs, often indicating liver or gallbladder inflammation.
Frequency: 60-75% of patients
Persistent fatigue
(constitutional)Overwhelming tiredness and lack of energy that does not improve with rest, often related to impaired liver function.
Frequency: 50-60% of patients
Nausea and vomiting
(gastrointestinal)Feeling of sickness with an urge to vomit, often occurring after meals due to impaired bile production and digestion.
Frequency: 40-50% of patients
Dark urine
(dermatologic)Urine that appears brown, amber, or tea-colored due to excess bilirubin being excreted by the kidneys.
Frequency: 40-50% of patients
Generalized itching
(dermatologic)Intense pruritus across the body caused by bile salt accumulation in the skin due to impaired bile flow.
Frequency: 15-25% of patients
Abdominal swelling
(gastrointestinal)Fluid accumulation in the abdomen causing visible distension, known as ascites, from portal hypertension.
Frequency: 10-20% of patients
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Healthy lifestyle changes and stress management
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Hepatobiliary-Friendly Dietary Modifications
Low-fat, moderate-protein diet with adequate complex carbohydrates and fiber. Small, frequent meals reduce bile duct压力 and support normal hepatobiliary physiology.
Hepatobiliary Function Serial Assessment
Regular laboratory monitoring of liver enzymes, bilirubin, and gallbladder function markers. This tracks physiologic improvement and identifies need for treatment escalation.
When to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Hepatobiliary System Physiology C6016356?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
AASLD. AASLD Guidelines for the Treatment of Hepatocellular Carcinoma. Hepatology. 2024.
European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of cholestatic liver diseases. J Hepatol. 2022.
Kuntz E, Kuntz HD. Hepatology: A Textbook of Liver Disease. 4th ed. Springer; 2022.
AASLD. The Diagnosis and Management of Primary Biliary Cholangitis. Hepatology. 2024.
Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 11th ed. Elsevier; 2021.
AASLD. Hepatic Encephalopathy in Chronic Liver Disease: 2023 Practice Guidance. Hepatology. 2023.
Cholestatic liver diseases: Pathogenesis and clinical practice. J Hepatol. 2021.
WHO. Guidelines on Hepatitis B and C Testing. World Health Organization; 2023.
AASLD/EASL. Joint Conference on Primary Sclerosing Cholangitis. Hepatology. 2022.
Alves-Bezerra M, Cohen DE. Triglyceride Metabolism in the Liver. Compr Physiol. 2021.
Medication Comparisons
Compare medications used to treat Abnormal Hepatobiliary System Physiology C6016356. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy